Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial.

Marc Colombel Axel Heidenreich Luis Martínez-Piñeiro Marko Babjuk Igor Korneyev Cristian Surcel Pavel Yakovlev Renzo Colombo Piotr Radziszewski Fred Witjes Raymond Schipper Peter Mulders Wim P J Witjes

Eur Urol

EAU Research Foundation, Arnhem, The Netherlands. Electronic address:

Published: March 2014

The European Association of Urology Research Foundation suggests exploring options beyond perioperative chemotherapy.
The MAGNOLIA study aims to assess the potential benefits of immunotherapy for patients with muscle-invasive bladder cancer.
This research could lead to new treatment pathways and improve outcomes for patients facing this type of cancer.

The European Association of Urology Research Foundation has proposed that alternatives to perioperative chemotherapy should be evaluated. The MAGNOLIA study represents a unique opportunity to investigate the concept of immunotherapy in muscle-invasive bladder cancer.

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2013.10.056	DOI Listing

Publication Analysis

Top Keywords

perioperative chemotherapy

muscle-invasive bladder

bladder cancer

chemotherapy muscle-invasive

cancer overview

overview unmet

unmet clinical

clinical alternative

alternative adjuvant

adjuvant therapy

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!